Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

Background & Aims: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular carcinoma). The aim of our study was to evaluate the risk of disease recurrence after LT and the factor...

Full description

Bibliographic Details
Main Authors: François Villeret, Sébastien Dharancy, Domitille Erard, Armand Abergel, Louise Barbier, Camille Besch, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Christophe Corpechot, Christophe Duvoux, François Faitot, Stéphanie Faure, Claire Francoz, Emiliano Giostra, Jean Gugenheim, Jean Hardwigsen, Marie-Noëlle Hilleret, Jean-Baptiste Hiriart, Pauline Houssel-Debry, Nassim Kamar, Guillaume Lassailly, Marianne Latournerie, Georges-Philippe Pageaux, Didier Samuel, Claire Vanlemmens, Faouzi Saliba, Jérôme Dumortier
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JHEP Reports
Subjects:
liver transplantation
NASH
metabolic syndrome
NAFLD recurrence
Bariatric surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555922002403

Internet

http://www.sciencedirect.com/science/article/pii/S2589555922002403

Similar Items